(S)-4-Fluoro-N-(piperidin-3-yl)benzamide hydrochloride, 95.0%, 1g

5-(3-Bromo-phenyl)-3-methyl-[1,2,4]oxadiazole, 95.0%, 1g

2-(Benzyloxy)acetaldehyde, 95.0%, 25g

2-amino-N,6-dimethyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide, 95.0%, 10g

Dicyclopentadiene (stabilised with BHT), 97.0%, 100g

1-(3-Bromomethyl-phenyl)-1H-pyrrole, 95.0%, 1g

1,4-Diazabicyclo[2.2.2]octane Dihydriodide>98.0%(T)1g

1-Pyridin-3-yl-piperazine, 98.0%, 5g

3-(4-Methylthiobenzoyl)propionic acid, 97.0%, 25g

Methanone, phenyl-2-pyridinyl-, 2-(5-chloro-2-pyridinyl)hydrazone, (E,E)-, 98%, 25mg

methyl 2-(2-acetamido-4-bromophenyl)acetate, 95.0%, 500mg

Ethyl 5-aminopicolinate, 95.0%, 100mg

Potassium Tetrakis(4-chlorophenyl)borate [Anion for the neutral carrier type ion electrode]>98.0%(HPLC)(W)5g